Henry Schein Medical Expands SolutionsHub with Colaborate

Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations

NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories. Together, Henry Schein and Colaborate will empower clinical laboratories across the U.S. to maintain compliance, enhance operational efficiency, and increase financial sustainability.

Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities. The Colaborate team is comprised of experienced business, technical, and advisory consultation professionals. Since 2005, Colaborate has served the needs of more than 500 institutions with billing and collections, compliance assessments, consolidation and merger assessments, contract reviews, equipment acquisitions, benchmarking, performance enhancements, and more.

"Clinical laboratories today face increasing financial pressures and regulatory demand, which can oftentimes be a struggle to balance," said Emily Jimenez, Director of Solution Sales at Henry Schein Medical. "By adding Colaborate to our SolutionsHub, we are continuing our mission to help our customers improve patient outcomes, increase profitability, and run a more efficient business."

Henry Schein and Colaborate are uniquely positioned to provide laboratories with resources and expertise to foster success for labs across the health care landscape.

"Joining forces with Henry Schein is an incredible milestone," said Kevin Hunter, Founder & CEO at Colaborate. "We're excited to bring our deep industry expertise to Henry Schein's vast network of customers. Our mission is clear: simplify laboratory builds and ongoing management, streamline regulatory compliance, and optimize financial outcomes – allowing health care organizations to focus on their core mission of exceptional patient care."

Henry Schein Medical supports laboratories by providing a wide range of products, services, and technology solutions tailored to their needs. This includes laboratory equipment, rapid diagnostics, and more.

"We are dedicated to serving laboratories with not only products, but also solutions that help our customers enhance financial and operational performance," said Gary Dennis, Senior Director of Laboratory Services at Henry Schein Medical. "Our relationship with Colaborate significantly advances our existing capabilities, helping our laboratory customers manage profitable laboratories while furthering optimal health outcomes."

To learn more about Colaborate or to explore Henry Schein Medical's full portfolio of solutions, please click here.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at

www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

Media Contacts:

Adam Hunter
Director, Colaborate
[email protected]

Lauren DelGuidice
Associate Manager, Corporate Media Relations, Henry Schein, Inc.
[email protected]
631.479.7309

SOURCE Colaborate